Fermata Advisors, LLC En V Veno Medical Corp Transaction History
Fermata Advisors, LLC
- $510 Million
- Q4 2024
A detailed history of Fermata Advisors, LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Fermata Advisors, LLC holds 35,706 shares of NVNO stock, worth $114,616. This represents 0.02% of its overall portfolio holdings.
Number of Shares
35,706
Previous 30,225
18.13%
Holding current value
$114,616
Previous $101,000
3.96%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding NVNO
# of Institutions
41Shares Held
5.72MCall Options Held
89.3KPut Options Held
5.2K-
Kingdon Capital Management, L.L.C. New York, NY859KShares$2.76 Million0.35% of portfolio
-
Perceptive Advisors LLC New York, NY694KShares$2.23 Million0.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT597KShares$1.92 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA589KShares$1.89 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL425KShares$1.36 Million0.01% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $30.4M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...